Literature DB >> 33492452

Efficacy of Tract Embolization After Percutaneous Pulmonary Radiofrequency Ablation.

Michael Dassa1, Jean Izaaryene2, Nassima Daidj2, Gilles Piana2.   

Abstract

PURPOSE: To evaluate the efficacy of tract embolization technique using gelatin sponge slurry with iodinated contrast medium (GSSI) to reduce the incidence of pneumothorax and chest tube placement after computed tomography-guided lung radiofrequency ablation (RFA).
MATERIALS AND METHODS: In this single-institute retrospective study, we examined all patients with metastatic cancer treated from January 2016 to December 2019 by interventional radiologists with computed tomography-guided lung RFA. Since 2017 in our institution, we have applied a tract embolization technique using GSSI for all RFA. Patients were included into those who underwent lung RFA performed either with GSSI (Group A) or without GSSI (Group B). Univariate and multivariate analyses were performed between the two groups to identify risk factors for pneumothorax and chest tube placement, including patient demographics and lesion characteristics.
RESULTS: This study included 116 patients (54 men, 62 women; mean age, 65 ± 11 years) who underwent RFA. Group A comprised 71 patients and Group B comprised 45 patients. Patients who underwent tract embolization had a significantly lower incidence of pneumothorax (Group A, 34% vs. Group B, 62%; p < 0.001) and chest tube insertion (Group A, 10% vs. Group B, 29%; p < 0.01). No embolic complications occurred. The hospitalization stay was significantly shorter in patients who underwent tract embolization (mean, 1.04 ± 0.2 days; p = 0.02).
CONCLUSION: Tract embolization after percutaneous lung RFA significantly reduced the rate of post-RFA pneumothorax and chest tube placement and was safer than the standard lung RFA technique.

Entities:  

Keywords:  Cancer; Chest tube; Gelfoam; Lung; Percutaneous radiofrequency ablation; Pneumothorax

Mesh:

Substances:

Year:  2021        PMID: 33492452     DOI: 10.1007/s00270-020-02745-6

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  31 in total

1.  Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study.

Authors:  Marcello Carlo Ambrogi; Olivia Fanucchi; Roberto Cioni; Paolo Dini; Annalisa De Liperi; Carla Cappelli; Federico Davini; Carlo Bartolozzi; Alfredo Mussi
Journal:  J Thorac Oncol       Date:  2011-12       Impact factor: 15.609

2.  Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.

Authors:  Hiran C Fernando; Alberto De Hoyos; Rodney J Landreneau; Sebastian Gilbert; William E Gooding; Percival O Buenaventura; Neil A Christie; Chandra Belani; James D Luketich
Journal:  J Thorac Cardiovasc Surg       Date:  2005-03       Impact factor: 5.209

Review 3.  Percutaneous thermal ablation of primary lung cancer.

Authors:  T de Baere; L Tselikas; V Catena; X Buy; F Deschamps; J Palussière
Journal:  Diagn Interv Imaging       Date:  2016-09-28       Impact factor: 4.026

Review 4.  Lung metastases.

Authors:  C J Herold; A A Bankier; D Fleischmann
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

5.  Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.

Authors:  Takao Hiraki; Hideo Gobara; Tatsuhiko Iishi; Yoshifumi Sano; Toshihiro Iguchi; Hiroyasu Fujiwara; Nobuhisa Tajiri; Jun Sakurai; Hiroshi Date; Hidefumi Mimura; Susumu Kanazawa
Journal:  J Thorac Cardiovasc Surg       Date:  2007-11       Impact factor: 5.209

6.  Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

Authors:  Caroline J Simon; Damian E Dupuy; Thomas A DiPetrillo; Howard P Safran; C Alexander Grieco; Thomas Ng; William W Mayo-Smith
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

7.  Metastatic patterns in adenocarcinoma.

Authors:  Kenneth R Hess; Gauri R Varadhachary; Sarah H Taylor; Wei Wei; Martin N Raber; Renato Lenzi; James L Abbruzzese
Journal:  Cancer       Date:  2006-04-01       Impact factor: 6.860

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.

Authors:  Michael D Beland; Elliot J Wasser; William W Mayo-Smith; Damian E Dupuy
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

10.  Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.

Authors:  T de Baère; A Aupérin; F Deschamps; P Chevallier; Y Gaubert; V Boige; M Fonck; B Escudier; J Palussiére
Journal:  Ann Oncol       Date:  2015-02-16       Impact factor: 32.976

View more
  1 in total

Review 1.  Current trends in image-guided chest interventions.

Authors:  Kenneth K Lau; Karin Steinke; Stephen Reis; Srinivas P Cherukuri; Manfred Cejna
Journal:  Respirology       Date:  2022-06-27       Impact factor: 6.175

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.